Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Cancer Research UK data shows death rates have fallen 11% in the last decade overall with significant falls in cancers such as breast cancer and cervical cancer ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

Whether the theory surrounding Supreme Leader Ayatollah Ali Khamenei proves true or not, it is a reminder that prostate cancer, in particular, often develops quietly and its early symptoms are most ...

More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...

Cancer Research UK has revealed that mortality rates from the disease have reached their lowest point in British history, marking a significant milestone in the nation's ongoing battle against cancer.

Colorectal cancer is increasing in younger patients and is now the leading cause of cancer death in those under age 50, yet those patients lack support.

Educating the public and raising awareness about health disparities in the community are among the goals of Minority Health Month. Held every April, local activities will include four health-focused ...

Nurses and advanced practice registered nurses (APRNs) play a central role in preventive care, screening, chronic disease management, and patient education. Expanding this workforce is particularly ...

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...